Aditxt, Inc. Unrealized Gain (Loss) on Investments
Aditxt, Inc. (ADTX) reported Unrealized Gain (Loss) on Investments of $23.77 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-03-31
- Aditxt, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $764.29K.
- Aditxt, Inc. unrealized gain (loss) on investments for fiscal 2025 was $23.77M.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|
| 2025-12-31 | $764.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $23.77M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $23.00M 10-Q · filed 2025-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |